Health TrialsbyHealthPanel

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

ConditionAlopecia Areata
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age12+
SponsorPfizer

About this trial

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Ritlecitinib

    Drug

    capsules

Treatment groups

No treatment groups listed

Trial outcomes

This trial has no outcomes listed.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Pfizer

Lead sponsor

Source ClinicalTrials.gov
Apply now